Gastrointestinal manifestations of hemolytic uremic syndrome: recognition of pancreatitis.
A retrospective study of 76 children with hemolytic uremic syndrome (HUS) who were admitted to the Alberta Children's Hospital in Calgary. Alberta between January 1982 and December 1988 was undertaken to explore the gastrointestinal manifestations of the syndrome. The children (mean age of 4.0 +/- 3.1 years) presented primarily during the summer months with a microangiopathic hemolytic anemia (Hgb 94 +/- 26 g/L), thrombocytopenia (platelets 87 +/- 83 X 10(9)/L), and acute renal failure (oligoanuria with a BUN of 26 +/- 15 mmol/L, and a creatinine of 294 +/- 90 mumol/L). Forty-three children required dialysis for 10 +/- 17 days. The duration of hospitalization was 17 +/- 17 days. Four children died of complications attributable to HUS. The following symptoms and gastrointestinal manifestations of HUS were noted: fever (33%), vomiting (80%), abdominal discomfort/tenderness (59%), diarrhea (100%), hemorrhagic colitis (79%), rectal prolapse (13%), colonic stricture (3%), colonic perforation (1%), intussusception (1%), indirect hyperbilirubinemia (49%), and elevated hepatocellular enzymes (58%). Of the last 29 children studied, 19 (66%) had elevated levels of amylase and lipase in the presence of acute renal failure, and six (21%) had a marked elevation of lipase (more than four times normal) with additional supportive evidence of pancreatitis. The additional supportive evidence included persistent elevation of lipase after the resolution of acute renal failure in four children, a marked increment in lipase in association with abdominal pain and an abnormal ultrasound of the pancreas after the initiation of oral feeding in a fifth child, and pancreatic exocrine and endocrine necrosis at autopsy in a sixth child.(ABSTRACT TRUNCATED AT 250 WORDS)
Department of Pediatrics, University of Calgary, Alberta, Canada.
S
S
Grodinsky
A
A
Telmesani
W L
WL
Robson
G
G
Fick
R B
RB
Scott
D058186:Acute Kidney Injury / Q000209:etiology / Q000628:therapy; D000293:Adolescent; D000681:Amylases / Q000097:blood; D002404:Catheterization / Q000009:adverse effects; D002648:Child; D002675:Child, Preschool; D004796:Clinical Enzyme Tests; D005260:Female; D005767:Gastrointestinal Diseases / Q000201:enzymology / Q000453:epidemiology / Q000209:etiology*; D006463:Hemolytic-Uremic Syndrome / Q000150:complications* / Q000201:enzymology / Q000453:epidemiology; D006801:Humans; D007223:Infant; D008049:Lipase / Q000097:blood; D008297:Male; D010195:Pancreatitis / Q000175:diagnosis* / Q000209:etiology; D010530:Peritoneal Dialysis / Q000009:adverse effects; D010538:Peritonitis / Q000188:drug therapy / Q000209:etiology; D012189:Retrospective Studies; D014552:Urinary Tract Infections / Q000188:drug therapy / Q000209:etiology
D008049:Lipase; D000681:Amylases